FundedIQ
Biotechnology

TuHURA Biosciences: Funding, Investors & Team (Oct 2026)

TuHURA Biosciences is a phase 3 registration-stage immuno-oncology company.

tuhurabio.com LinkedIn Tampa, United States 11-50 employees
Biopharma Biotechnology Life Science
Total raised
$50.0M
Rounds
1
Latest
Undisclosed round
Apr 2026

TuHURA Biosciences has raised $50.0M across 1 funding round on record, the most recent an undisclosed round of $50.0M announced in Apr 2026.

That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

TuHURA Biosciences Company Profile and Key Stats

Total funding raised
$50.0M
across 1 round on record
Funding rounds on record
1
Latest funding round
Undisclosed round
$50.0M in Apr 2026
Employees
11-50
reported band
Headquarters
Tampa, United States

Latest funding round on record: Apr 2026.

TuHURA Biosciences Funding Rounds

Date
Round
Amount
Undisclosed round
$50.0M

TuHURA Biosciences Founders and Leadership Team

Name
Role
Contact
James A
Founder
—

No contact details are on record for this team yet.

TuHURA Biosciences Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.1M
30,234
$7.6M

TuHURA Biosciences' latest round of $50.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like TuHURA Biosciences in Biotechnology and Tampa

Companies Similar to TuHURA Biosciences

Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…

Series E $92.5M

Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…

Series B $40.0M

TuHURA Biosciences Funding FAQs

What does TuHURA Biosciences do?

TuHURA Biosciences is a phase 3 registration-stage immuno-oncology company.

How much funding has TuHURA Biosciences raised?

TuHURA Biosciences has raised $50.0M across 1 round on record. The most recent is an undisclosed round of $50.0M announced in Apr 2026.

When did TuHURA Biosciences last raise funding?

TuHURA Biosciences' most recent funding round on record is an undisclosed round of $50.0M, announced in Apr 2026.

Who founded TuHURA Biosciences?

FundedIQ lists James A (Founder) at TuHURA Biosciences.

Where is TuHURA Biosciences headquartered?

TuHURA Biosciences is based in Tampa, Florida, United States.

How many employees does TuHURA Biosciences have?

TuHURA Biosciences is in the 11-50 employee band.

How does TuHURA Biosciences' funding compare to other Biotechnology startups?

TuHURA Biosciences' latest round of $50.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's TuHURA Biosciences Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for TuHURA Biosciences is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.